KATHERINE ARENSMEYER
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health SALISBURY, MD NPI 1609106517
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health MD Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$4,019.21
- Category: General Payments
- Program years: PY2021–2024
- Record count: 77
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,925.28 across 50 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,780.30 | 48 |
| Education | $144.98 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $452.38 | 5 |
| PFIZER INC. | $218.05 | 5 |
| Acerta Pharma LLC | $168.00 | 6 |
| Daiichi Sankyo Inc. | $152.68 | 2 |
| ABBVIE INC. | $141.39 | 2 |
| BeiGene USA, Inc. | $96.70 | 3 |
| Exelixis Inc. | $76.45 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $64.90 | 2 |
| Lilly USA, LLC | $55.23 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $50.90 | 2 |
| EISAI INC. | $49.64 | 2 |
| GlaxoSmithKline, LLC. | $48.43 | 2 |
| Incyte Corporation | $45.09 | 2 |
| Gilead Sciences, Inc. | $41.30 | 2 |
| Karyopharm Therapeutics Inc. | $31.05 | 1 |
| GENZYME CORPORATION | $26.29 | 1 |
| Mirati Therapeutics, Inc. | $25.82 | 1 |
| Immunocore Limited | $25.22 | 1 |
| TAIHO ONCOLOGY, INC. | $24.67 | 1 |
| PharmaEssentia USA Corporation | $23.52 | 1 |
| Astellas Pharma US Inc | $23.26 | 1 |
| Merck Sharp & Dohme Corporation | $21.90 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $21.42 | 1 |
| ADC Therapeutics America, Inc. | $20.67 | 1 |
| Regeneron Healthcare Solutions, Inc. | $20.32 | 1 |
By program year
Records — PY2024 (50)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.